Millipore Sigma Vibrant Logo

3779 Histamine, Free Base - CAS 51-45-6 - Calbiochem

A potent vasodilator found in normal tissues and blood. Activates nitric oxide synthase.

MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: 2-(4-Imidazolyl)ethylamine

View Products on Sigmaaldrich.com
3779
  
Ricerca del prezzo in corso...
Non è stato possibile trovare il prezzo
La quantità minima deve essere un multiplo di
Maximum Quantity is
Al termine dell'ordine Maggiori informazioni
Lei ha salvato ()
 
—
Richiedi il prezzo
—
Adempimento e consegna in ritardo Adempimento e consegna in ritardo
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

       

      Contatti il Servizio Clienti

      Panoramica

      Replacement Information

      Tabella delle specifiche principali

      CAS #Empirical Formula
      51-45-6C₅H₉N₃
      Description
      OverviewA potent vasodilator found in normal tissues and blood. Activates nitric oxide synthase. Formed by the decarboxylation of L-histidine. Activation of histamine H1 receptors leads to Ca2+ mobilization, whereas histamine H2 receptor activation stimulates adenylate cyclase activity in neurons. Stimulated time- and concentration-dependent increase in p38 and p42/p44 MAP kinases in DDT(1) MF2 cells.
      Catalogue Number3779
      Brand Family Calbiochem®
      Synonyms2-(4-Imidazolyl)ethylamine
      References
      ReferencesRobinson, A.J., and Dickerson, J.M. 2001. Br. J. Pharmacol. 133, 178.
      Izumi, H., et al. 1995. Am. J. Obstet. Gynecol. 172, 1477.
      Vannier, E., and Dinarello, C.A. 1994. J. Biol. Chem. 269, 9952.
      Yan, Q.Z., et al. 1994. Agents Actions 41, C111.
      Moncada, S., et al. 1991. Pharmacol. Rev. 43, 109.
      Bloom, F.E. 1990. in Pharmacological Basis of Therapeutics p. 224 (Gilman, A.G., et al., Eds.) Pergamon Press, New York.
      Product Information
      CAS number51-45-6
      FormWhite solid
      Hill FormulaC₅H₉N₃
      Chemical formulaC₅H₉N₃
      Hygroscopic Hygroscopic
      Structure formula ImageStructure formula Image
      Quality SegmentMQ100
      Applications
      Biological Information
      Purity≥97% by TLC
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSMS1050000
      Safety Information
      R PhraseR: 22-36/37/38-42/43

      Harmful if swallowed.
      Irritating to eyes, respiratory system and skin.
      May cause sensitization by inhalation and skin contact.
      S PhraseS: 26-36/37-22

      In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
      Wear suitable protective clothing and gloves.
      Do not breathe dust.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade ITEM Number
      Numero di catalogo GTIN
      3779 0

      Documentation

      Histamine, Free Base - CAS 51-45-6 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      Histamine, Free Base - CAS 51-45-6 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      3779

      Riferimenti bibliografici

      Panoramica delle referenze
      Robinson, A.J., and Dickerson, J.M. 2001. Br. J. Pharmacol. 133, 178.
      Izumi, H., et al. 1995. Am. J. Obstet. Gynecol. 172, 1477.
      Vannier, E., and Dinarello, C.A. 1994. J. Biol. Chem. 269, 9952.
      Yan, Q.Z., et al. 1994. Agents Actions 41, C111.
      Moncada, S., et al. 1991. Pharmacol. Rev. 43, 109.
      Bloom, F.E. 1990. in Pharmacological Basis of Therapeutics p. 224 (Gilman, A.G., et al., Eds.) Pergamon Press, New York.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision21-June-2011 JSW
      Synonyms2-(4-Imidazolyl)ethylamine
      DescriptionA potent vasodilator found in normal tissues and blood. Formed by the decarboxylation of L-histidine. Activates nitric oxide synthase (NOS), resulting in the release of nitric oxide. Activation of histamine H1 receptors leads to Ca2+ mobilization; whereas, histamine H2 receptor activation stimulates adenylate cyclase activity in neurons. Inhibits the synthesis of IL-2 and γ-IFN in peripheral blood mononuclear cells and lipopolysaccharide-induced synthesis of TNF-α in monocytes via H2 receptor activation.
      FormWhite solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number51-45-6
      RTECSMS1050000
      Chemical formulaC₅H₉N₃
      Structure formulaStructure formula
      Purity≥97% by TLC
      SolubilityH₂O (1 mg/ml)
      Storage Protect from light
      +2°C to +8°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Harmful
      Merck USA index14, 4719
      ReferencesRobinson, A.J., and Dickerson, J.M. 2001. Br. J. Pharmacol. 133, 178.
      Izumi, H., et al. 1995. Am. J. Obstet. Gynecol. 172, 1477.
      Vannier, E., and Dinarello, C.A. 1994. J. Biol. Chem. 269, 9952.
      Yan, Q.Z., et al. 1994. Agents Actions 41, C111.
      Moncada, S., et al. 1991. Pharmacol. Rev. 43, 109.
      Bloom, F.E. 1990. in Pharmacological Basis of Therapeutics p. 224 (Gilman, A.G., et al., Eds.) Pergamon Press, New York.